Log inSign up
AAOIFI No. 21 screening

Is TAK halal?

Takeda Pharmaceutical Company L

Not halal

Takeda Pharmaceutical Company L did not pass AAOIFI screening. The failed check is shown below.

Checked: 13 October 2026

Exchange

NYSE

Price

19.67

Day

+1.13%

Market cap

$59.67B

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

What the company does

Takeda (Japan) is a drugmaker focused on gastrointestinal disease (Entyvio), rare blood disorders, oncology and vaccines. Revenue comes from prescription-drug sales; trades as an ADR.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $31.12B ÷ 36-month average market cap (estimated) $47.91B = 65.0%

    65.0%

    Fail

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $6.24B ÷ 36-month average market cap (estimated) $47.91B = 13.0%

    13.0%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $106.33M ÷ annual revenue $28.39B (2026) = 0.4%

    0.4%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $59.67B.

For information (AAOIFI 3/1 note): cash + receivables are 9.5% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 1 superinvestors · Average reported price: $16.03

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Drug Manufacturers - Specialty & Generic — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyTAK's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →
Is TAK halal? — Takeda Pharmaceutical Company L AAOIFI screening result — Limitup